Quick answer: Peptide therapy is one of the fastest-growing and least-marketed cash-pay categories in medicine, which makes it a rare opportunity: real patient demand, high margins, and almost no established marketing competition. The catch is compliance. Peptides sit in a shifting regulatory space, and advertising platforms are cautious, so the practices that win market through education and provider authority rather than direct treatment claims. This guide covers how to acquire peptide patients compliantly, why the category is wide open right now, and how to show up when patients ask AI about peptide therapy.
Peptide therapy has moved from a niche corner of functional and regenerative medicine into a genuine consumer-demand category, pulled along by the broader interest in longevity, performance, recovery, and weight management. Patients are searching for it. Very few practices have built the content to be found. That gap is the opportunity.
Why peptide marketing is different (and wide open)
Most cash-pay medical categories are crowded — every plastic surgeon and med spa is fighting for the same searches. Peptide therapy isn't there yet. When a patient asks Google or ChatGPT about peptides for recovery, weight management, or longevity, there's relatively little authoritative, practice-level content to answer them. That means a practice that publishes credible, well-structured content can own the category's search and AI visibility far more easily than in a saturated specialty.
The tradeoff is that peptides sit in a more uncertain regulatory space than established treatments, and that landscape shifts. Some peptides face restrictions; platform advertising policies are cautious. So the marketing has to be built carefully — which, again, is a moat, because most competitors won't do it well.
Market compliantly: education and authority, not claims
The rule that governs peptide marketing is the same one that governs regenerative medicine: market the practice, the providers, and patient education — not specific treatment-outcome claims. Given the regulatory uncertainty around some peptides, this is even more important. You build content around your clinical approach, your providers' expertise, what peptide therapy involves, and the kinds of patients you help — not promises about results. Get compliance review on anything specific.
Done this way, education is the marketing. Peptide patients are curious, informed, and skeptical of hype. Content that explains the category honestly, sets realistic expectations, and demonstrates real clinical understanding converts far better than promotional messaging — and keeps you clear of the claims that draw scrutiny.
What to build
Provider authority content. Peptide patients want to know the person prescribing has genuine expertise, not a drop-shipping side hustle. Named providers, credentials, clinical philosophy. This is the strongest trust and AI-citation signal you can build.
Education content by use case. Patients search by goal — recovery, performance, weight management, longevity, healing. Build content around the goals patients actually search for, explaining your clinical approach to each, in plain language.
Direct-answer FAQ content. "What is peptide therapy," "is peptide therapy safe," "what does peptide therapy cost," "who is a candidate." These are exactly the questions patients ask AI tools, and structured answers get your practice cited in those responses.
Candidacy and consultation framing. Peptide therapy works best as a guided, medically-supervised program. Content that positions it that way — a real clinical relationship, not a vending machine — attracts better patients and separates you from the low-quality operators flooding the space.
The AI search advantage in an emerging category
Here's why peptides are worth prioritizing now: emerging categories have a content vacuum in AI search. When there's little authoritative content on a topic, AI engines cite whatever credible content exists — and the bar to be that source is much lower than in a category like plastic surgery, where established players dominate every answer.
Peptide therapy is squarely in that window. A practice that publishes structured, provider-backed, honest content on peptides can become the source AI reaches for when patients ask — and can hold that position as the category grows. The practices that wait until peptide marketing is crowded will be fighting for scraps. The ones building now are claiming the category.
How to measure it
Peptide therapy is typically a program or membership model, so the real number is cost per enrolled patient measured against program lifetime value, not cost per lead. A guided peptide program with good retention has strong lifetime economics, which means you can invest more to acquire the right patient — as long as you're tracking to enrollment and retention, not raw inquiries.
Frequently asked questions
Can you legally advertise peptide therapy?
It depends on the specific peptides and the current regulatory environment, which shifts. The safe approach is to market the practice, providers, and patient education rather than making treatment claims, and to get compliance review on specific messaging. Platform advertising policies for the category are cautious, so organic content and authority often carry more of the load than paid ads.
Why is peptide therapy a good marketing opportunity right now?
Demand is growing quickly while marketing competition remains thin. Few practices have built authoritative content, so there's an open window to own the category's search and AI visibility before it gets crowded.
How do peptide patients find a provider?
Increasingly through search and AI tools — asking about specific goals like recovery, performance, weight management, or longevity. Practices with credible, structured, provider-backed content get found and recommended; practices with a thin single page don't.
What's the best way to market peptides given the compliance uncertainty?
Education and authority. Explain your clinical approach and who you help without promising outcomes, position peptide therapy as a supervised program rather than a product, and keep specific claims under compliance review. This both converts skeptical patients and keeps you clear of enforcement risk.
How do I get my peptide practice cited in AI search?
Publish credible content with named, credentialed providers and direct-answer FAQ and use-case pages. Because peptides are an emerging category with little established content, the threshold to become the source AI cites is lower than in saturated specialties — but that window narrows as more practices catch on.
Mike Funkhouser is the founder of Practice Growth Co, a healthcare marketing agency focused on patient acquisition for specialty medical practices, and a contributor to Medical Economics on AI search and patient acquisition. [Book a strategy call](/book-a-strategy-call).